Tompkins Financial’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Buy
+2,200
New +$421K 0.03% 134
2025
Q2
Sell
-81
Closed -$11.1K 551
2025
Q1
$11.1K Hold
81
﹤0.01% 441
2024
Q4
$12.4K Hold
81
﹤0.01% 420
2024
Q3
$15.7K Hold
81
﹤0.01% 437
2024
Q2
$18.8K Hold
81
﹤0.01% 441
2024
Q1
$17.5K Hold
81
﹤0.01% 450
2023
Q4
$21K Hold
81
﹤0.01% 420
2023
Q3
$20.8K Buy
+81
New +$21.7K ﹤0.01% 404
2016
Q3
Sell
-43
Closed -$10K 394
2016
Q2
$10K Hold
43
﹤0.01% 392
2016
Q1
$11K Buy
+43
New +$11.4K ﹤0.01% 374
2015
Q4
Sell
-88
Closed -$26K 511
2015
Q3
$26K Sell
88
-91
-51% -$30.1K 0.01% 347
2015
Q2
$73K Sell
179
-32
-15% -$12.8K 0.02% 226
2015
Q1
$89K Buy
211
+179
+559% +$70.6K 0.02% 221
2014
Q4
$11K Hold
32
﹤0.01% 371
2014
Q3
$11K Sell
32
-5
-14% -$1.65K ﹤0.01% 368
2014
Q2
$12K Hold
37
﹤0.01% 366
2014
Q1
$11K Buy
37
+5
+16% +$1.59K ﹤0.01% 378
2013
Q4
$9K Buy
+32
New +$8.28K ﹤0.01% 416

Other funds holding BIIB

Tompkins Financial's BIIB Position: Q2 2026 in Review

Tompkins Financial opened a new position in Biogen (BIIB) in Q2 2026: 2,200 shares worth $475K. The stake represents 0.03% of the portfolio and ranks #134 among its holdings. This is a return to the name: Tompkins Financial previously reported a position in BIIB as recently as Q1 2025.

Tompkins Financial first reported a position in BIIB in Q4 2013 and has held it in 18 quarters since. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Tompkins Financial held 2,200 shares of Biogen worth $475K as of Q2 2026.
  • Biogen was a new Tompkins Financial position in Q2 2026.
  • Biogen made up 0.03% of Tompkins Financial's portfolio in Q2 2026, its #134 holding.
  • Tompkins Financial first reported a position in Biogen in Q4 2013 and has held it in 18 quarters since.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.